Phase 3 Readout~month
Phase 3 Topline: A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of
- Drug
- acquired
- Indication
- Hypothalamic Obesity
Other upcoming events for RYTM
Phase 2 ReadoutPhase 2 Readout: setmelanotide
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial: Multiple Independent Sub-studies of S
Phase 3 ReadoutPhase 3 Topline: A Phase 3, Double Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of
Patent ExpiryPatent/Exclusivity Expiry: IMCIVREE
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.